Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kronos Worldwide (KRO) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Kronos Worldwide (KRO) over the last 17 years, with Q3 2025 value amounting to $409.9 million.

  • Kronos Worldwide's Cost of Revenue rose 688.4% to $409.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 166.71%. This contributed to the annual value of $1.5 billion for FY2024, which is 174.48% up from last year.
  • As of Q3 2025, Kronos Worldwide's Cost of Revenue stood at $409.9 million, which was up 688.4% from $431.6 million recorded in Q2 2025.
  • Kronos Worldwide's Cost of Revenue's 5-year high stood at $444.8 million during Q2 2022, with a 5-year trough of $305.1 million in Q4 2022.
  • For the 5-year period, Kronos Worldwide's Cost of Revenue averaged around $383.5 million, with its median value being $383.0 million (2025).
  • Its Cost of Revenue has fluctuated over the past 5 years, first surged by 2736.04% in 2021, then plummeted by 1917.88% in 2022.
  • Quarter analysis of 5 years shows Kronos Worldwide's Cost of Revenue stood at $377.5 million in 2021, then fell by 19.18% to $305.1 million in 2022, then increased by 12.91% to $344.5 million in 2023, then fell by 2.26% to $336.7 million in 2024, then grew by 21.74% to $409.9 million in 2025.
  • Its Cost of Revenue was $409.9 million in Q3 2025, compared to $431.6 million in Q2 2025 and $383.0 million in Q1 2025.